Friday, September 4, 2026
ExploreSearch
Via News
MarketCommodities

Coffee Futures Bullish Momentum With A 8% Rise In The Last 21 Sessions

Coffee Futures Bullish Momentum With A 8% Rise In The Last 21 Sessions

(VIANEWS) - Coffee (KC) has been up by 8.47% for the last 21 sessions. At 13:55 EST on Wednesday, 1 March, Coffee (KC) is $185.00.

Volume

Today's last reported volume for Coffee is 21394, 15.41% above its average volume of 18536.5.

Volatility

Coffee's last week, last month's, and last quarter's current intraday variation average was a negative 1.39%, a positive 0.76%, and a positive 2.18%, respectively.

Coffee's highest amplitude of average volatility was 3.11% (last week), 2.47% (last month), and 2.18% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Coffee's commodity is considered to be oversold (<=20).

More news about Coffee (KC).

Categories

MarketCommodities

Tags

CommodityCommoditiesFuturesPrice UpCommodities Price UpCommodities NowKCCoffee
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com